Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 and zolpidem drug-drug interaction study in healthy volunteers
NL-OMON37431Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mirogabalin and zolpidem in diabetic neuropathy and postherpetic neuralgia (PHN) (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Effect of zolpidem on DS-5565 pharmacokinetics, Safety and tolerability of DS-5565 with zolpidem and 2 more. Started Feb 2012; status: active, not recruiting.
02
Drugs
mirogabalinzolpidem
03
Conditions
diabetic neuropathypostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NL-OMON37431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37431.